These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 22335945)
1. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting]. Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945 [TBL] [Abstract][Full Text] [Related]
2. Targeted tumor gene therapy based on loss of IGF2 imprinting. Pan Y; He B; Li T; Zhu C; Zhang L; Wang B; Xu Y; Qu L; Hoffman AR; Wang S; Hu J Cancer Biol Ther; 2010 Aug; 10(3):290-8. PubMed ID: 20592487 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting. Pan Y; He B; Lirong Z; Nie Z; Chen L; Gu L; Hoffman AR; Wang S; Hu J Oncol Rep; 2013 Oct; 30(4):1814-22. PubMed ID: 23900345 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting. Sun H; Pan Y; He B; Deng Q; Li R; Xu Y; Chen J; Gao T; Ying H; Wang F; Liu X; Wang S Int J Oncol; 2015 Apr; 46(4):1759-67. PubMed ID: 25625919 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system. Nie ZL; Pan YQ; He BS; Gu L; Chen LP; Li R; Xu YQ; Gao TY; Song GQ; Hoffman AR; Wang SK; Hu JF Mol Cancer; 2012 Nov; 11():86. PubMed ID: 23171475 [TBL] [Abstract][Full Text] [Related]
6. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter]. Zhou HK; Yang DH; Tang SH; Huang W; Lu XH Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system. Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886 [TBL] [Abstract][Full Text] [Related]
8. [Reconstruction of adenovirus vector contained canstatin gene and hTERT gene core promoter and its anti-tumor effect in human ovarian cancer]. Zhu BJ; Qiao YH; Li Y Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):214-8. PubMed ID: 19570449 [TBL] [Abstract][Full Text] [Related]
9. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro]. Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225 [TBL] [Abstract][Full Text] [Related]
10. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma]. Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324 [TBL] [Abstract][Full Text] [Related]
11. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y; Shen K; He CX Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518 [TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene]. Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973 [TBL] [Abstract][Full Text] [Related]
13. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652 [TBL] [Abstract][Full Text] [Related]
14. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells]. Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458 [TBL] [Abstract][Full Text] [Related]
15. [Construction of a recombinant adenovirus Ad5F35-SD-EGFP and its effect on K562 cell proliferation]. Shi J; Hu J; Xiao Q; Peng Z; Cao WX; Luo QP; Wang F; Feng WL Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1806-11. PubMed ID: 22126755 [TBL] [Abstract][Full Text] [Related]
16. [Enhanced transduction efficiency of adeno-associated virus on cancer cells with the help of low dose adenovirus]. Li HM; Wang F; Wei F; Dong XY; Wang HP; Qiu W; Zhang JF; Chen XF; Wu XB; Huang Q Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1987-90. PubMed ID: 17923042 [TBL] [Abstract][Full Text] [Related]
17. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
18. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y; Shen K; Yu JR Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289 [TBL] [Abstract][Full Text] [Related]
20. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism]. Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]